3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
3
Small Cell Lung Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage III Lung Non-Small Cell Cancer AJCC v7
1
Sarcoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Liver Cirrhosis
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Breast Neoplasms
1
Interventions
pembrolizumab
4
Cisplatin
4
Gemcitabine
3
Carboplatin
3
Docetaxel
2
Bupropion
2
tocilizumab
1
tislelizumab
1
spartalizumab
1
infigratinib
1
etoposide phosphate
1
cc-486
1
avelumab
1
Zoledronic Acid
1
Vorinostat
1
Varenicline
1
Tobacco Use Cessation Devices
1
Radiotherapy, Intensity-Modulated
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Pilocarpine
1
Oral Hygiene
1
Nivolumab
1
Nicotine Replacement Therapy
1
Nicotine
1
NVP-BKM120
1
Ifosfamide
1
Gene Expression Profiling
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Nasopharyngeal Neoplasms
×
fluoromisonidazole
×
Clear all
No trials found.